New phase I immuno-oncology study for HPV16+ cancers
An unmet clinical need exists for patients with cancers associated with human papillomavirus. A new phase I study at Providence Cancer Institute will evaluate a novel biologic therapy in patients with
Cancer Immunotherapy Month
June is Cancer Immunotherapy MonthTM, an initiative to call attention to cancer immunotherapy, a specialized field focused on harnessing the power of the immune system to cure cancer.
Providence at forefront of COVID-19 clinical research
The outbreak of coronavirus disease 2019 (COVID-19) brought about an unprecedented global threat to public health. Providence has been at the forefront of COVID-19 treatment and research in the United
Providence cancer researchers highlighted at ASCO20: Virtual
Researchers at the Earle A. Chiles Research Institute, a division of Providence Cancer Institute in Portland, Oregon, will join oncology professionals around the world for the 2020 ASCO Virtual Scient